`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`APOTEX INC.,
`Petitioner,
`
`v.
`
`REGENERON PHARMACEUTICALS, INC.,
`Patent Owner
`
`——————————
`
`Case IPR2022-00298
`U.S. Patent No. 9,254,338 B2
`
`PATENT OWNER’S MANDATORY NOTICES
`
`
`
`Case IPR2022-00298
`U.S. Patent No. 9,254,338 B2
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Regeneron Pharmaceuticals, Inc.
`
`(“Patent Owner”) respectfully submits the following mandatory notices in response
`
`to Petitioner Celltrion, Inc.’s (“Petitioner”) Petition for Inter Partes Review of U.S.
`
`Patent No. 9,254,338 B2 (“the ’338 patent”).
`
`I.
`
`37 C.F.R. § 42.8(b)(1): NOTICE OF REAL PARTY-IN-INTEREST
`
`The ’338 patent is currently assigned to Regeneron Pharmaceuticals, Inc.
`
`II.
`
`37 C.F.R. § 42.8(b)(2): RELATED MATTERS
`
`The ’338 patent is also being challenged in Mylan Pharmaceuticals Inc. v.
`
`Regeneron Pharmaceuticals, Inc., Case No. IPR2021-00881 (P.T.A.B.) and
`
`Celltrion, Inc. v. Regeneron Pharmaceuticals, Inc., Case No. IPR2022-00258
`
`(P.T.A.B.). Patent Owner understands that Petitioner has filed a Motion for Joinder
`
`on December 9, 2021 requesting joinder of this case with IPR2021-00881.
`
`The ’338 patent is related to U.S. Patent No. 9,669,069 B2 (“the ’069
`
`patent”). Petitioner has separately filed an IPR petition on the ’069 Patent
`
`(IPR2022-00301). The ’069 patent is also being challenged in Mylan
`
`Pharmaceuticals Inc. v. Regeneron Pharmaceuticals, Inc., Case No. IPR2021-
`
`00880 (P.T.A.B.) and Celltrion, Inc. v. Regeneron Pharmaceuticals, Inc., Case No.
`
`IPR2022-00257 (P.T.A.B.).
`
`III.
`
`37 C.F.R. § 42.8(b)(3): LEAD AND BACK-UP COUNSEL
`
`Patent Owner identifies the following lead and back-up counsel:
`
`-2-
`
`
`
`Case IPR2022-00298
`U.S. Patent No. 9,254,338 B2
`
`Lead Counsel
`Deborah E. Fishman (Reg. No. 48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deboarh.Fishman@arnoldporter.com
`
`-3-
`
`Back-Up Counsel
`David A. Caine (Reg. No. 52,683)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4710
`Facsimile: 650.319.4573
`David.Caine@arnoldporter.com
`
`Alice S. Ho (Lim. Rec. No. L1162)
`Victoria Reines (pro hac vice to be
`applied for)
`Jeremy Cobb (pro hac vice to be
`applied for)
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Telephone: 202.942.5000
`Facsimile: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Jeremy.Cobb@arnoldporter.com
`
`Daniel Reisner (pro hac vice to be
`applied for)
`Matthew M. Wilk (pro hac vice to be
`applied for)
`Arnold & Porter Kaye Scholer LLP
`250 West 55th Street
`New York, NY 10019-9710
`Telephone: 212.836.8000
`Facsimile: 212.836.8689
`Daniel.Reisner@arnoldporter.com
`Matthew.Wilk@arnoldporter.com
`
`
`
`Case IPR2022-00298
`U.S. Patent No. 9,254,338 B2
`
`A concurrently filed power of attorney identifies the practitioners of Arnold
`
`& Porter Kaye Scholer LLP (Customer Number 180441), including Deborah E.
`
`Fishman, David A. Caine, Alice S. Ho, Victoria Reines, Jeremy Cobb, Daniel
`
`Reisner, and Matthew M. Wilk as attorneys of record.
`
`IV.
`
`37 C.F.R. § 42.8(b)(4): SERVICE INFORMATION
`
`Patent Owner may be served at the addresses found in Part III. Patent Owner
`
`consents to electronic service at:
`
`− Deborah.Fishman@arnoldporter.com
`
`− David.Caine@arnoldporter.com
`
`− Alice.Ho@arnoldporter.com
`
`− Victoria.Reines@arnoldporter.com
`
`− Jeremy.Cobb@arnoldporter.com
`
`− Daniel.Reisner@arnoldporter.com
`
`− Matthew.Wilk@arnoldporter.com
`
`− RegeneronEyleaIPRs@arnoldporter.com
`
`-4-
`
`
`
`Case IPR2022-00298
`U.S. Patent No. 9,254,338 B2
`
`Dated: February 1, 2022
`
`Respectfully submitted,
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deborah.Fishman@arnoldporter.com
`
`David A. Caine (Reg. No. 52,683)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4710
`Facsimile: 650.319.4573
`David.Caine@arnoldporter.com
`
`Alice S. Ho (Lim. Rec. No. L1162)
`Victoria Reines (pro hac vice to be applied for)
`Jeremy Cobb (pro hac vice to be applied for)
`Arnold & Porter Kaye Scholer LLP
`601 Massachusetts Ave., N.W.
`Washington D.C. 20001
`Telephone: 202.942.5000
`Facsimile: 202.942.5999
`Alice.Ho@arnoldporter.com
`Victoria.Reines@arnoldporter.com
`Jeremy.Cobb@arnoldporter.com
`
`Daniel Reisner (pro hac vice to be applied for)
`Matthew M. Wilk (pro hac vice to be applied for)
`Arnold & Porter Kaye Scholer LLP
`250 West 55th Street
`New York, NY 10019-9710
`Telephone: 212.836.8000
`
`-5-
`
`
`
`Case IPR2022-00298
`U.S. Patent No. 9,254,338 B2
`
`Facsimile: 212.836.8689
`Daniel.Reisner@arnoldporter.com
`Matthew.Wilk@arnoldporter.com
`
`Attorneys for Patent Owner
`Regeneron Pharmaceuticals, Inc.
`
`-6-
`
`
`
`Case IPR2022-00298
`U.S. Patent No. 9,254,338 B2
`
`CERTIFICATE OF SERVICE
`The undersigned certifies that a copy of the foregoing PATENT OWNER’S
`
`MANDATORY NOTICES was served on February 1, 2022, to the following
`
`Counsel for Petitioner via e-mail:
`
`Teresa Stanek Rea (Reg. No. 30,427)
`TRea@Crowell.com
`Deborah H. Yellin (Reg. No. 45,904)
`DYellin@Crowell.com
`Shannon M. Lentz (Reg. No. 65,382)
`SLentz@Crowell.com
`Crowell & Moring LLP
`Intellectual Property Group
`1001 Pennsylvania Avenue, N.W.
`Washington DC 20004-2595
`Telephone: (202) 624-2620
`Facsimile: (202) 628-5116
`
`Attorneys for Petitioner Apotex Inc.
`
`/s/ Deborah E. Fishman
`Deborah E. Fishman (Reg. No. 48,621)
`Arnold & Porter Kaye Scholer LLP
`3000 El Camino Real
`Five Palo Alto Square, Suite 500
`Palo Alto, California 94306-3807
`Telephone: 650.319.4519
`Facsimile: 650.319.4573
`Deboarh.Fishman@arnoldporter.com
`
`-i-
`
`